Core Insights - Health Catalyst (HCAT) reported quarterly earnings of $0.04 per share, exceeding the Zacks Consensus Estimate of $0.03 per share, but down from $0.12 per share a year ago, indicating an earnings surprise of +33.33% [1] - The company generated revenues of $80.72 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.24% and up from $75.9 million year-over-year [2] - Health Catalyst shares have declined approximately 46% year-to-date, contrasting with the S&P 500's gain of 7.9% [3] Earnings Outlook - The future performance of Health Catalyst's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.08 on revenues of $85.38 million, and for the current fiscal year, it is $0.24 on revenues of $334.82 million [7] Industry Context - The Medical Info Systems industry, to which Health Catalyst belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]